drugset / Trial / NCT02245672

MGR001 / Advair Diskus Local Equivalence Study in Asthma

NCT02245672

Phase 3 Completed 1128 enrolled Mylan Pharma UK Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether MGR001 is equivalent to Advair Diskus when administered by inhalation in adult asthma patients

Timeline

Start
2014-10
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified 100 ug Inhaled
Subject salmeterol xinafoate Unknown 50 ug Inhaled

Indications